Abstract
| Chronic Urticaria and Irritable Bowel Syndrome: a Cross-Sectional Study of 11,271 Patients Shalom G1,2, Magen E2,3,4, Babaev M2, Horev A1,2, Freud T5, Ben Yakov G2,6, Comaneshter D7, Vardy DA1,2, Cohen AD5,7. Br J Dermatol. 2017 Sep 14. doi: 10.1111/bjd.15997. [Epub ahead of print] |
| Author information 1 Department of Dermatology and Venereology, Soroka Medical Center, Beer-Sheva, Israel. 2 Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel. 3 Medicine C Department, Allergy and Clinical Immunology Unit, Barzilai Medical Center, Ben-Gurion University of Negev, Ashkelon, Israel. 4 Leumit Health Services, Israel. 5 Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel. 6 Institute for Gastroenterology and Hepatology, Soroka Medical Center, Beer-Sheva, Israel. 7 Chief Physician's Office, Department of Quality Measurements and Research, Clalit Health Services, Tel-Aviv, Israel. Abstract The human body interacts with the environment mainly through three major tissues: the lungs, skin, and gastrointestinal (GI) tract. In each one, an intensive nervous network is present, conjugated with abundant mast cells (MC). While MC-mediated disorders in airways and the skin are extensively discussed, MC-mediated disorders of the GI tract remain relatively uncommon. Since the GI tract is one of the three main environment-interacting tissues, it is reasonable that MC-mediated disorders of the GI may have the same weight and impact as asthma or chronic urticaria (CU). |
© Copyright 2013-2025 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only.
Use of this website is governed by the GIHF terms of use and privacy statement.
